These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2427840)

  • 21. Effects of celiprolol on cardiovascular reactivity to laboratory stressors in patients with hypertension.
    Cardillo C; Degen C; De Felice F; Folli G
    Clin Pharmacol Ther; 1992 May; 51(5):555-61. PubMed ID: 1534042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
    Parati G; Pomidossi G; Casadei R; Ravogli A; Trazzi S; Mutti E; Mancia G
    J Int Med Res; 1988; 16 Suppl 1():52A-61A. PubMed ID: 2975612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the antihypertensive effects of celiprolol and acebutolol.
    Terziivanov D; Vlahov V; Belovezhdov N; Gerova Z
    Eur J Clin Pharmacol; 1988; 34(2):125-8. PubMed ID: 2968268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
    Matthys H; Doshan HD; Rühle KH; Applin WJ; Braig H; Pohl M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
    Leary P; Mayol R; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():70-2. PubMed ID: 2864068
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive effect of trimepranol, a new beta-blocking agent.
    Jounela AJ; Pentikäinen PJ; Neuvonen PJ
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of celiprolol and placebo in the treatment of hypertension.
    Capone P; Mayol R
    Br J Clin Pract Suppl; 1985 Jun; 40():65-9. PubMed ID: 2864067
    [No Abstract]   [Full Text] [Related]  

  • 34. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoneutral effects in hypertensive asthmatics--celiprolol versus chlorthalidone.
    Dorow P
    J Int Med Res; 1988; 16 Suppl 1():23A-26A. PubMed ID: 2975609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celiprolol and verapamil in the treatment of essential hypertension.
    McInnes GT; McLenachan JM; Henderson E; Herrick AL; Dargie HJ
    Am Heart J; 1988 Nov; 116(5 Pt 2):1437-8. PubMed ID: 2903656
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
    van Hoof R; Desager JP; Harvengt C; Fagard R; Lijnen P; Peerenboom P; Staessen J; Thijs L; Van Mieghem W; Amery A
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):268-73. PubMed ID: 1381018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety profile of celiprolol.
    Lamon KD
    Am Heart J; 1988 Nov; 116(5 Pt 2):1438-40. PubMed ID: 2903657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celiprolol in angina pectoris: a controlled study.
    Eff J; Godfrey J; Garutti R; Capone P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S132-4. PubMed ID: 2427843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
    Lucarini AR; Salvetti A
    Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.